What question did this study set out to answer?

This research aims to explore the role of plasma proteomics in diagnosing and monitoring degenerative cervical myelopathy.

March 31, 2026Open Access

Plasma proteomics implicates NOX-driven redox imbalance in degenerative cervical myelopathy: findings from the Australian MYelopathy Natural History Registry AO Spine RECODE-DCM research priority number 5

Key Points

This research aims to explore the role of plasma proteomics in diagnosing and monitoring degenerative cervical myelopathy.
Utilized plasma proteomics as a liquid biopsy method for analysis.
Conducted a modest cohort study with multivariate analyses.
Addressed confounding factors such as age and adiposity.
Supported the feasibility of using plasma for diagnosing cervical myelopathy.
Identified potential redox imbalance driven by NOX.
Highlighted the need for larger cohort studies and validation.

Abstract

Findings support the feasibility of a plasma 'liquid biopsy' to augment diagnosis and monitoring. The modest cohort size and potential confounding by age and adiposity, absolute quantification, multivariate adjustment, and external validation are warranted to establish specificity and clinical utility.

Plasma proteomics implicates NOX-driven redox imbalance in degenerative cervical myelopathy: findings from the Australian MYelopathy Natural History Registry AO Spine RECODE-DCM research priority number 5

Key Points

Abstract

Cite This Study